Evidence-Based Complementary and Alternative Medicine

Pharmacological Potential of Natural Products Against Cardiovascular Diseases


Publishing date
01 Jan 2023
Status
Published
Submission deadline
19 Aug 2022

1Lahore College for Women University (LCWU), Lahore, Pakistan

2Princess Nourah Bint Abdul Rahman University, Riyadh, Saudi Arabia

3Shaheed Benazir Bhutto University, Sheringal, Pakistan

4University of Agricultural Sciences and Veterinary Medicine, Cluj-Napoca, Romania


Pharmacological Potential of Natural Products Against Cardiovascular Diseases

Description

From time immemorial, plant extracts and bioactive compounds isolated from plants have been used for cardiovascular health. The wide variety of biologically active compounds isolated from plants for many centuries is being used as crude material or as pure compounds for treating various cardiovascular diseases. Cardiovascular diseases (CVD) are one of the leading causes of mortality and incapacity worldwide. Medication therapy options will vary depending on the particular type of CVD. Many patients are intolerant of the therapeutic options available. On this premise, the emerging need for new drug options is highlighted, where those obtained from medicinal plants stand out, which are immeasurable sources of thousands of secondary metabolites with significant therapeutic potential.

Until a few decades ago, medicinal plants were used with impressively little knowledge about their actual properties. In most cases, the biological role of plant extracts and phyto-compounds is not really known. However, now studies are oriented towards an in-depth analysis of the valuable compounds in these plants which can be used for treating CVD and knowledge about their mechanism of action.

The rationalization of ethnomedicinal uses of plants is an important area of research in complementary and alternative medicine. This Special Issue encourages scholarly work indicating the mechanism of action of plant extracts and compounds present in these extracts against cardiovascular diseases. This Special Issue aims to collect original research and review articles regarding research into plant extracts, and bioactive compounds used against cardiovascular ailments.

Potential topics include but are not limited to the following:

  • Assessment of pharmacological properties of plants against cardiovascular diseases
  • In-vitro studies about the evaluation of plant extracts and bioactive compounds against cardiovascular diseases
  • In-silico studies of bioactive compounds against cardiovascular diseases
  • Plant-derived nanomaterials against cardiovascular diseases
  • Identification and characterization of phytochemicals from medicinal plants used around the world against cardiovascular diseases
  • Systematic reviews and meta-analyses on the potential of plant-based remedies for treating cardiovascular diseases
  • Basic research - in vivo and in vitro study, network pharmacology study, bioinformatics study, and pre-clinical research for treating cardiovascular diseases
  • Critical reviews of the historical, clinical, and legal status of medicinal plants used in the management of cardiovascular diseases

Articles

  • Special Issue
  • - Volume 2022
  • - Article ID 1864116
  • - Research Article

[Retracted] Fut7 Promotes Adhesion and Invasion of Acute Lymphoblastic Leukemia Cells through the Integrin/Fak/Akt Pathway

Fei He | Lijun Yi | Changcheng Lai
  • Special Issue
  • - Volume 2022
  • - Article ID 1572249
  • - Research Article

[Retracted] Identification of Differentially Expressed Long Noncoding RNAs as Functional Biomarkers and Construction of Function Enrichment Network in Oral Squamous Cell Carcinoma

Fang Xiao | Ke Wang | ... | Yanzhen Zhang
  • Special Issue
  • - Volume 2022
  • - Article ID 6720287
  • - Research Article

[Retracted] The Influence of Family-Oriented Enabling Psychological Nursing on Posttraumatic Stress and Fear of Recurrence in Patients with Cervical Cancer

Yue Shi | Zhongye Wu | ... | Xiaowan Zhuansun
  • Special Issue
  • - Volume 2022
  • - Article ID 1378976
  • - Research Article

[Retracted] Quercetin Inhibits KBM7R Cell Proliferation through Wnt/β-Catenin Signaling

Wei Li | Yang Yu | ... | Qinghua Tang
  • Special Issue
  • - Volume 2022
  • - Article ID 9239662
  • - Research Article

[Retracted] Investigations on the Changes of Serum Proteins in Rabbits after Trimeresurus stejnegeri Venom Injection via Mass Spectrometry-Based Proteomics

Shijun Wang | Weilian Yang | ... | Tao Chen
  • Special Issue
  • - Volume 2022
  • - Article ID 2285728
  • - Research Article

[Retracted] Jujuboside A Ameliorates Myocardial Apoptosis and Inflammation in Rats with Coronary Heart Disease by Inhibiting PPAR-α Signaling Pathway

Chunfang Hu | Zhiyuan Zhang | ... | Zhongbao Ruan
  • Special Issue
  • - Volume 2022
  • - Article ID 5063625
  • - Research Article

[Retracted] Porcine Fibrin Sealant Promotes Skin Wound Healing in Rats

Lihuo Zhang | Lu Liu | ... | Ping Zhou
  • Special Issue
  • - Volume 2022
  • - Article ID 9630716
  • - Research Article

[Retracted] Sufentanil Alleviates Sepsis-Induced Myocardial Injury and Stress Response in Rats through the ERK/GSK-3β Signaling Axis

Hongcheng Zang | Gang Shao | Ying Lou
  • Special Issue
  • - Volume 2022
  • - Article ID 4950414
  • - Research Article

[Retracted] Total Saikosaponins Attenuates Depression-Like Behaviors Induced by Chronic Unpredictable Mild Stress in Rats by Regulating the PI3K/AKT/NF-κB Signaling Axis

Zhicong Zhou | Hui Chen | ... | Huancun Feng
  • Special Issue
  • - Volume 2022
  • - Article ID 8644353
  • - Research Article

[Retracted] Poricoic Acid A Inhibits the NF-κB/MAPK Pathway to Alleviate Renal Fibrosis in Rats with Cardiorenal Syndrome

Wenzhong Chen | Zhiwen Fan | ... | Junying Liu
Evidence-Based Complementary and Alternative Medicine
 Journal metrics
See full report
Acceptance rate7%
Submission to final decision145 days
Acceptance to publication29 days
CiteScore3.500
Journal Citation Indicator-
Impact Factor-

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.